Frontiers in Pharmacology (Dec 2023)

Retraction: Berberine maintains the neutrophil N1 phenotype to reverse cancer cell resistance to doxorubicin

  • Frontiers Editorial Office

DOI
https://doi.org/10.3389/fphar.2023.1349235
Journal volume & issue
Vol. 14

Abstract

Read online

No abstracts available.